secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001171843-26-001972
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian FY2025 net sales down 13% to $10.5M; net income falls to $2.1M ($0.46/share)
--------------------------------------------------------------------------------

- Net sales $10.5M, down 13% from $12.2M in FY2024; net income $2.1M ($0.46/share) vs $3.3M ($0.71/share) prior year.
- Cosmetic ingredient sales declined due to excess inventory at distributor Ashland Specialty Ingredients and weaker China demand.
- Pharmaceuticals up 15%, medical lubricants up 4% YoY; Renacidin added to two major pharmacy benefit manager formularies.
- Management optimistic about new marketing agreements and distributor efforts to regain market share in coming years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184326001972/0001171843-26-001972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184326001972/f8k_032626.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer